
Overview
Ronald Potkul is an Oncologist in Naperville, Illinois. Dr. Potkul is rated as an Experienced provider by MediFind in the treatment of BRCA Positive Breast Cancer. His top areas of expertise are Endometrial Cancer, Vulvar Cancer, Ovarian Cancer, Lymphadenectomy, and Oophorectomy.
His clinical research consists of co-authoring 19 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
- MEDICARE MAPD
- MEDICARE SNP
Locations
120 Spalding Dr., Suite 111, Naperville, IL 60540
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Endeavor Health Medical Group
Allison DePersia, MD, a medical oncologist at Endeavor Health, specializes in inherited cancer syndromes with a focus on cancer risk assessment, screening and prevention. She supports individuals with increased cancer risk by reviewing family history, genetic testing and other key factors to build personalized screening plans. Dr. DePersia integrates evolving research and innovative screening methods, including emerging blood-based technologies, to help identify cancer earlier when it is more treatable. Her clinical approach emphasizes proactive care grounded in evidence-based practice. Dr. Depersia is rated as an Advanced provider by MediFind in the treatment of BRCA Positive Breast Cancer. Her top areas of expertise are BRCA Positive Breast Cancer, HER2 Negative Breast Cancer, DICER1 Syndrome, and Breast Cancer.
Endeavor Health Medical Group
Elena Susana Moore, MD, a gynecologic oncologist at Endeavor Health, provides expert care for patients with cancers of the female reproductive system. She treats conditions such as cervical, endometrial and ovarian cancer, and performs procedures including hysterectomy, cancer staging and chemotherapy. Dr. Moore works with multidisciplinary teams to guide patients through diagnosis, treatment and recovery. Dr. Moore is rated as a Distinguished provider by MediFind in the treatment of BRCA Positive Breast Cancer. Her top areas of expertise are Endometrial Stromal Sarcoma, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Vulvar Cancer, and Oophorectomy.
Endeavor Health Medical Group
Mary Jenkins Vogel, MD, a gynecologic oncologist at Endeavor Health, provides advanced cancer care for women using innovative treatments tailored to each patient’s condition. She specializes in personalized medicine, using molecular profiling and the latest research to improve outcomes in endometrial and ovarian cancer. Dr. Jenkins Vogel values collaboration, ensuring patients are supported and involved in every step of their care journey. Dr. Vogel is rated as a Distinguished provider by MediFind in the treatment of BRCA Positive Breast Cancer. Her top areas of expertise are Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Ovarian Carcinosarcoma, and Bladder Reconstruction.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Cervical CancerDr. Potkul isDistinguished. Learn about Cervical Cancer.
- Endometrial CancerDr. Potkul isDistinguished. Learn about Endometrial Cancer.
- Endometrial Stromal SarcomaDr. Potkul isDistinguished. Learn about Endometrial Stromal Sarcoma.
- Malignant Mixed Mullerian TumorDr. Potkul isDistinguished. Learn about Malignant Mixed Mullerian Tumor.
- MelanomaDr. Potkul isDistinguished. Learn about Melanoma.
- Neuroendocrine Carcinoma of the CervixDr. Potkul isDistinguished. Learn about Neuroendocrine Carcinoma of the Cervix.
- Advanced
- Bartholin Cyst or AbscessDr. Potkul isAdvanced. Learn about Bartholin Cyst or Abscess.
- Desmoplastic Small Round Cell Tumor
- EndometritisDr. Potkul isAdvanced. Learn about Endometritis.
- Lump in the AbdomenDr. Potkul isAdvanced. Learn about Lump in the Abdomen.
- LymphadenectomyDr. Potkul isAdvanced. Learn about Lymphadenectomy.
- Neonatal Ovarian CystDr. Potkul isAdvanced. Learn about Neonatal Ovarian Cyst.
- Experienced
- AdenomyosisDr. Potkul isExperienced. Learn about Adenomyosis.
- Adult Soft Tissue SarcomaDr. Potkul isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Anal CancerDr. Potkul isExperienced. Learn about Anal Cancer.
- AngiomyomaDr. Potkul isExperienced. Learn about Angiomyoma.
- Bladder ReconstructionDr. Potkul isExperienced. Learn about Bladder Reconstruction.
- BRCA Positive Breast CancerDr. Potkul isExperienced. Learn about BRCA Positive Breast Cancer.


